| Outreach Behavior Support | |
|
4935 Makenna Cir Pace FL 32571-1175 | |
| (850) 227-6946 | |
| Not Available |
| Full Name | Outreach Behavior Support |
|---|---|
| Speciality | Behavior Analyst |
| Location | 4935 Makenna Cir, Pace, Florida |
| Authorized Official Name and Position | Zachary Howze (CEO) |
| Authorized Official Contact | 9502276946 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Outreach Behavior Support 4935 Makenna Cir Pace FL 32571-1175 Ph: () - | Outreach Behavior Support 4935 Makenna Cir Pace FL 32571-1175 Ph: (850) 227-6946 |
| NPI Number | 1750070058 |
|---|---|
| Provider Enumeration Date | 05/02/2023 |
| Last Update Date | 05/02/2023 |
| Certification Date | 05/02/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750070058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Every addiction is characterized by a strong desire for a certain addictive substance, be it nicotine, alcohol or other drug. Researchers at the University of Basel in Switzerland recently conducted a study on heroin addiction and demonstrated that the stress hormone cortisol can reduce addictive cravings.
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.
NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.
Spectrum Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Prior Approval Supplement containing data providing for the removal of the Indium-111 ZEVALIN® (ibritumomab tiuxetan) pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.
› Verified 7 days ago
Freedom Fighters Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5568 Woodbine Rd # 1027, Pace, FL 32571 Phone: 850-726-3239 Fax: 937-962-6210 | |
Behavior Quest Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5345 Highway 90, Pace, FL 32571 Phone: 850-626-0606 | |
Accent Usa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4273 Dana St, Pace, FL 32571 Phone: 850-865-3981 Fax: 866-675-6298 | |
Leisa D. Ludlam, Ph.d.,p.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4509 Woodbine Rd, Pace, FL 32571 Phone: 850-995-2500 Fax: 850-995-2501 | |
Cornerstone Counseling And Wellness Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4286 Woodbine Rd Ste A, Pace, FL 32571 Phone: 850-259-9501 | |
Partners Family Medicine Practice & Recovery Center Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4453 Highway 90, Pace, FL 32571 Phone: 850-905-0110 | |
Pace Pastoral Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4587 Woodbine Rd, Pace, FL 32571 Phone: 850-995-9732 |